Lilly’s COVID-19 antibody drug authorized for use in children
December 03, 2021 at 17:22 PM EST
Eli Lilly & Co.’s monoclonal antibody drug has been cleared for emergency use in children under the age of 12, the Food and Drug Administration said on Friday.